{"DataElement":{"publicId":"3607636","version":"1","preferredName":"Clinical Study Protocol Therapy Begin Administration Yes No Indicator","preferredDefinition":"information related to start of administration of  therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"3607635v1.0:3461455v1.0","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"3607635","version":"1","preferredName":"Clinical Study Protocol Therapeutic Procedure Begin Administration","preferredDefinition":"information related to start of administration of  therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"2469576v1.0:3607633v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2697293","version":"1","preferredName":"Clinical Trial Protocol Therapeutic Procedure","preferredDefinition":"An action plan for a clinical trial.  The plan states what the study will do, how, and why.  It explains how many people will be in it, who is eligible to participate, what study agents or other interventions they will be given, what tests they will receive and how often, and what information will be gathered.:An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"C25320:C49236","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Study Protocol","conceptCode":"C25320","definition":"A formal document that describes a complete plan of research activity in the framework of a clinical study; specifically, the study objective(s), design, methodology, eligibility requests for prospective subjects and controls; intervention regimen(s), proposed methods of analysis of data; statistical considerations, and organization of the study. The protocol usually also provides the background and rationale for the study, but these could be represented in other protocol referenced documents.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3EFDB7C2-E2A9-6BB0-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-11-15","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-11-15","modifiedBy":"ONEDATA","dateModified":"2007-11-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3607633","version":"1","preferredName":"Begin Administration","preferredDefinition":"Have a beginning, in a temporal, spatial, or evaluative sense.:The act of administration.","longName":"C25431:C25409","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Begin","conceptCode":"C25431","definition":"Have a beginning, in a temporal, spatial, or evaluative sense; the point in space or time where something begins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Administration","conceptCode":"C25409","definition":"The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CB929CE9-B3FB-BB38-E040-BB89AD435A80","latestVersionIndicator":"Yes","beginDate":"2012-10-08","endDate":null,"createdBy":"ALAIS","dateCreated":"2012-10-08","modifiedBy":"ONEDATA","dateModified":"2012-10-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CB929CE9-B40C-BB38-E040-BB89AD435A80","latestVersionIndicator":"Yes","beginDate":"2012-10-08","endDate":null,"createdBy":"ALAIS","dateCreated":"2012-10-08","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506068","version":"1","preferredName":"Yes No Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"YES_NO_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75C2-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75CC-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2421125","version":"1","preferredName":"Ind-2","preferredDefinition":"A caDSR representation term that is used to indicate a question with permissible values of yes/no","longName":"C38147","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes or No Response","conceptCode":"C38147","definition":"A response or indicator that can have a value of either yes or no.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"0303DF01-F4B4-15EC-E044-0003BA3F9857","latestVersionIndicator":"No","beginDate":"2005-10-18","endDate":"2016-04-27","createdBy":"SHIDED","dateCreated":"2005-10-18","modifiedBy":"TAYLORT","dateModified":"2020-10-03","changeDescription":"10.3.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Changed Workflow Status DBW 04-27-2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C37A1BEB-75AE-B6C9-E040-BB89AD434179","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":"8/29/17 tt added CSI per Round 5 finalization task. 3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]},{"publicId":"3896529","version":"1","longName":"Consortia 2012 Studies","context":"DCP","ClassificationSchemeItems":[{"publicId":"4528052","version":"1","longName":"MAY2013-02-01","context":"DCP"}]}],"AlternateNames":[{"name":"ECOG-ACRIN","type":"USED_BY","context":"ECOG-ACRIN"},{"name":"COG","type":"USED_BY","context":"COG"},{"name":"SttPrtTx","type":"COG GDE Short Name","context":"COG"},{"name":"DCP","type":"USED_BY","context":"DCP"},{"name":"CCTG","type":"USED_BY","context":"CCTG"},{"name":"PROT_TX_BEG_ADM_IND","type":"OID, CCTG","context":"CCTG"},{"name":"3607635v1.0:3461455v1.0","type":"USED_BY","context":"CCTG"},{"name":"IE_IEORRES_TXSTART","type":"OID, CCTG","context":"CCTG"}],"ReferenceDocuments":[{"name":"Will the patient start protoc","type":"Preferred Question Text","description":"Will the patient start protocol treatment","url":null,"context":"CTEP"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Will the patient proceed to protocol treatment?","url":null,"context":"CTEP"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"Did patient start protocol treatment?","url":null,"context":"COG"},{"name":"ECOG CRF 1","type":"Alternate Question Text","description":"Will patient start treatment","url":null,"context":"ECOG-ACRIN"},{"name":"COG CRF Text 3","type":"Alternate Question Text","description":"Did patient start Blinatumomab-S therapy?","url":null,"context":"CTEP"},{"name":"ECOG CRF Text 2","type":"Alternate Question Text","description":"Will the patient receive this step's protocol treatment?","url":null,"context":"ECOG-ACRIN"},{"name":"MA39","type":"Alternate Question Text","description":"Protocol treatment will begin within 3 weeks of patient randomization","url":null,"context":"CCTG"},{"name":"CE7","type":"Alternate Question Text","description":"Protocol therapy will begin within 14 days of randomization.","url":null,"context":"CCTG"},{"name":"COG CRF Text 01","type":"Alternate Question Text","description":"Did patient start protocol therapy?","url":null,"context":"COG"},{"name":"ALT_MA39_1","type":"Alternate Question Text","description":"Protocol treatment will begin within 6 weeks of patient randomization.","url":null,"context":"CCTG"},{"name":"CCTG_01","type":"Alternate Question Text","description":"Protocol treatment will begin within 7 working days of patient enrollment?","url":null,"context":"CCTG"},{"name":"CCTG_03","type":"Alternate Question Text","description":"Investigator confirms patient is planned for definitive RT or CRT with bilateral neck RT.","url":null,"context":"CCTG"},{"name":"CCTG_02","type":"Alternate Question Text","description":"Protocol treatment (i.e. definitive RT) will begin within 28 days (+14 days) of randomization?","url":null,"context":"CCTG"},{"name":"ECOG-ACRIN - 1","type":"Alternate Question Text","description":"Does the patient plan to start a standard neoadjuvant Pertuzumab (or other biosimilars) based regimen?","url":null,"context":"ECOG-ACRIN"},{"name":"ECOG-ACRIN - 2","type":"Alternate Question Text","description":"If the patient completed the baseline (T0) FDG-PET/CT prior to registration, will the patient start the neoadjuvant Pertuzumab-based regimen after study registration, and within 21 days after the T0 scan?","url":null,"context":"ECOG-ACRIN"},{"name":"CCTG_04","type":"Alternate Question Text","description":"Protocol treatment will begin within 12 weeks of participant enrollment.","url":null,"context":"CCTG"}],"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CB929CE9-B450-BB38-E040-BB89AD435A80","latestVersionIndicator":"Yes","beginDate":"2012-10-08","endDate":null,"createdBy":"ALAIS","dateCreated":"2012-10-08","modifiedBy":"CLOHNES","dateModified":"2023-11-16","changeDescription":null,"administrativeNotes":"11/16/23 Added AQT for CCTG ticket number CADSR0003085 cjl","unresolvedIssues":null,"deletedIndicator":"No"}}